文献速递乳房整形与再造美容整形

跨性别女性注射外来物质所致肉芽肿性乳房畸形的手术治疗:病例系列与算法

Surgical Treatment of Granulomatous Breast Deformities Caused by Injection of Foreign Substances in Transgender Women: A Case Series and Algorithm.
PubMed 文献 · Plast Reconstr Surg · 2022-03-29

该病例系列纳入2016年1月至2020年2月间因自由注射外来物质导致乳房肉芽肿性畸形而接受手术治疗的7例跨性别女性,年龄29至53岁,6例在美国境外接受注射,平均就诊时间为注射后19.3±15.7年。4例在作者机构接受分期重建,平均随访10.7±12.6个月,无重大并发症,最常见轻微并发症为伤口愈合延迟。作者认为经仔细考量与患者选择,可安全成功完成乳房重建,并提供基于患者因素的算法指导治疗决策,但需进一步研究确定其普适性。

要点

  • 7例跨性别女性因自由注射外来物质致乳房肉芽肿性畸形接受手术治疗。
  • 6例在美国境外接受注射,平均注射至就诊时间19.3±15.7年。
  • 4例在作者机构行分期重建,平均随访10.7±12.6个月,无重大并发症。

核心结论

  • 作者认为,经仔细考量与患者选择,可为跨性别女性外来物质肉芽肿行安全成功的乳房重建。
  • 作者提供基于患者因素的算法指导该人群治疗决策,但需进一步研究确定其普适性与适用性。

研究设计与样本

  • 病例系列,纳入2016年1月至2020年2月因自由注射外来物质所致乳房肉芽肿性畸形就诊的跨性别女性7例。
  • 证据等级:治疗性,IV级。

主要发现

  • 患者年龄29至53岁,全部为西班牙裔/拉丁裔,5例以西班牙语为主要语言,全部持有公共保险。
  • 7例中6例在美国境外接受自由注射外来物质,从初次注射至就诊平均时间19.3±15.7年。
  • 3例有既往其他外科医生修复史,4例在作者机构接受分期重建。
  • 初次手术后平均随访10.7±12.6个月,无重大并发症,最常见轻微并发症为伤口愈合延迟。

临床怎么用

  • 作者认为,经仔细考量与患者选择,可安全成功完成乳房重建以处理跨性别女性外来物质肉芽肿。
  • 作者提供基于患者因素的算法指导该人群治疗决策,但需进一步研究确定其普适性与适用性。

局限性

  • 原文指出需进一步研究以确定该算法的普适性与适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SUMMARY: Despite potentially devastating complications, free foreign substance injections for feminizing breast augmentation remain common among transgender women. To date, the literature regarding surgical treatment of these deformities among transgender women remains limited. The authors present a case series of transgender women presenting for surgical management of granulomatous breast deformities secondary to free foreign substance injections between January of 2016 and February of 2020. Seven transgender women presented for surgical management of complications secondary to free foreign substance injections of the breast. These patients ranged in age from 29 to 53 years, all identified as Hispanic/Latinx, and five were primarily Spanish speakers. All were recipients of public insurance. Six of the seven patients received free foreign substance injections outside of the United States, with an average time from initial injections to presentation of 19.3 ± 15.7 years. Three patients presented with a history of prior revisions by other surgeons. Four underwent staged reconstruction at the authors' institutions. Patients were followed for, on average, 10.7 ± 12.6 months after their initial surgery. There were no major complications. The most common minor complication was delayed wound healing. In the present series, the authors illustrate that, with careful consideration and patient selection, it is possible to perform safe and successful breast reconstruction for the management of foreign substance granulomas in transgender women. They also provide an algorithm based on patient-specific factors to guide treatment decisions in this patient population. Further research is needed to determine the generalizability and applicability of this algorithm. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Cordero DM, Srinivasa D, Barnes LL, et al. Surgical Treatment of Granulomatous Breast Deformities Caused by Injection of Foreign Substances in Transgender Women: A Case Series and Algorithm. Plast Reconstr Surg. 2022. PMID: 35349530. doi:10.1097/PRS.0000000000009092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。